221 related articles for article (PubMed ID: 27981514)
21. Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity.
Yang L; Samarasinghe YP; Kane P; Amiel SA; Aylwin SJ
Clin Endocrinol (Oxf); 2010 Aug; 73(2):197-200. PubMed ID: 20050862
[TBL] [Abstract][Full Text] [Related]
22. Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women.
Fernández Muñoz MJ; Basurto Acevedo L; Córdova Pérez N; Vázquez Martínez AL; Tepach Gutiérrez N; Vega García S; Rocha Cruz A; Díaz Martínez A; Saucedo García R; Zárate Treviño A; González Escudero EA; Degollado Córdova JA
Rev Esp Cardiol (Engl Ed); 2014 Jun; 67(6):436-41. PubMed ID: 24863591
[TBL] [Abstract][Full Text] [Related]
23. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
24. Low cardiorespiratory fitness levels and elevated blood pressure: what is the contribution of visceral adiposity?
Rhéaume C; Arsenault BJ; Bélanger S; Pérusse L; Tremblay A; Bouchard C; Poirier P; Després JP
Hypertension; 2009 Jul; 54(1):91-7. PubMed ID: 19470873
[TBL] [Abstract][Full Text] [Related]
25. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease.
Sironi AM; Petz R; De Marchi D; Buzzigoli E; Ciociaro D; Positano V; Lombardi M; Ferrannini E; Gastaldelli A
Diabet Med; 2012 May; 29(5):622-7. PubMed ID: 22023514
[TBL] [Abstract][Full Text] [Related]
26. Autonomic Dysfunction is Associated with Increased Cardiometabolic Risk in Patients with Childhood-Onset Craniopharyngioma.
Jung HW; Kim HY; Kim JY; Cheon JE; Kim IO; Kim SK; Shin CH; Yang SW; Lee YA
Horm Metab Res; 2020 Jul; 52(7):500-508. PubMed ID: 32512610
[TBL] [Abstract][Full Text] [Related]
27. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.
Zheng SH; Li XL
Gynecol Endocrinol; 2016; 32(3):177-83. PubMed ID: 26502288
[TBL] [Abstract][Full Text] [Related]
28. Visceral adiposopathy: a vascular perspective.
Farb MG; Gokce N
Horm Mol Biol Clin Investig; 2015 Feb; 21(2):125-36. PubMed ID: 25781557
[TBL] [Abstract][Full Text] [Related]
29. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
30. SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.
Numan Ahmad M; Halim Haddad F
Nutr Hosp; 2015 Dec; 32(6):2701-9. PubMed ID: 26667723
[TBL] [Abstract][Full Text] [Related]
31. Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood.
Tan HC; Roberts J; Catov J; Krishnamurthy R; Shypailo R; Bacha F
Pediatr Diabetes; 2015 Sep; 16(6):419-26. PubMed ID: 25800542
[TBL] [Abstract][Full Text] [Related]
32. Visceral adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74.
Dereziński T; Zozulińska-Ziółkiewicz D; Uruska A; Dąbrowski M
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3052. PubMed ID: 30064156
[TBL] [Abstract][Full Text] [Related]
33. Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men.
Oka R; Kobayashi J; Inazu A; Yagi K; Miyamoto S; Sakurai M; Nakamura K; Miura K; Nakagawa H; Yamagishi M
Metabolism; 2010 May; 59(5):748-54. PubMed ID: 19926101
[TBL] [Abstract][Full Text] [Related]
34. Features of the metabolic syndrome after childhood craniopharyngioma.
Srinivasan S; Ogle GD; Garnett SP; Briody JN; Lee JW; Cowell CT
J Clin Endocrinol Metab; 2004 Jan; 89(1):81-6. PubMed ID: 14715831
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
36. Associations of liver fat content with cardiometabolic phenotypes and outcomes in a multi-ethnic population: Results from the Dallas Heart Study.
Le MD; Wu Y; Berry JD; Browning JD; de Lemos JA; Neeland IJ; Lingvay I
Diabetes Obes Metab; 2023 Feb; 25(2):586-595. PubMed ID: 36317522
[TBL] [Abstract][Full Text] [Related]
37. Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy.
Klaver M; van Velzen D; de Blok C; Nota N; Wiepjes C; Defreyne J; Schreiner T; Fisher A; Twisk J; Seidell J; T'Sjoen G; den Heijer M; de Mutsert R
J Clin Endocrinol Metab; 2022 Jan; 107(1):e153-e164. PubMed ID: 34415999
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome.
O'Gorman CS; Syme C; Lang J; Bradley TJ; Wells GD; Hamilton JK
Clin Endocrinol (Oxf); 2013 Jun; 78(6):907-13. PubMed ID: 23106295
[TBL] [Abstract][Full Text] [Related]
39. Intramyocellular lipid is associated with visceral adiposity, markers of insulin resistance, and cardiovascular risk in prepubertal children: the EPOCH study.
Brumbaugh DE; Crume TL; Nadeau K; Scherzinger A; Dabelea D
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1099-105. PubMed ID: 22508709
[TBL] [Abstract][Full Text] [Related]
40. Trajectories of total and central adiposity throughout adolescence and cardiometabolic factors in early adulthood.
Araújo J; Barros H; Ramos E; Li L
Int J Obes (Lond); 2016 Dec; 40(12):1899-1905. PubMed ID: 27677621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
